GC Corp. (KRX:005257)

South Korea · Delayed Price · Currency is KRW · Preferred Stock

18,000

+320 (1.81%)

Sep 3, 2026, 3:30 PM KST

-33.33% (1Y)

Market Cap	634.72B -3.0%
Revenue (ttm)	2.40T +9.9%
Net Income	127.58B
EPS	2,832.40
Shares Out	n/a
PE Ratio	4.98
Forward PE	n/a
Dividend	300.00 (1.69%)
Ex-Dividend Date	Mar 30, 2026

Volume	344
Open	17,640
Previous Close	17,680
Day's Range	17,640 - 18,800
52-Week Range	13,700 - 31,700
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About GC Corp.

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; a... [Read more]

Industry Pharmaceutical Preparations

Sector Healthcare

Founded 1967

Employees 144

Stock Exchange Korea Stock Exchange

Ticker Symbol 005257